In a prominent presentation during the "Middle East Regenerative Medicine Conference 2025," Dr. Amina Dababseh presented the results of a comprehensive study investigating the safety and efficacy of using Mesenchymal Stem Cells (MSCs)
Research Center
In a move that reflects the global pioneering role of the I.D. Stem Cells and Genome Institute, the institute's director, Professor Dr. Islam Dababseh, has been invited to participate as a speaker at the Middle
- global announcement from Ukraine: I.D. Stem Cells and Genome Institute announces a new dawn in human medicine
- Participation of the Institute, represented by Dr. Islam Dababseh, in the monthly meeting of the American Society for Regenerative Medicine (ASRM)
- Global Announcement from Ukraine: I.D. Stem Cells and Genome Institute Announces a New Dawn in Human Medicine
- Promising Japanese Achievement: Genetic Engineering Targets the Primary Cause of Down Syndrome
- A Pioneering Scientific Partnership Between the University of Sharjah, I.D. Institute for Stem Cells and Genes, and the Funding Company Alfa Group
- Institute's Participation Represented by Dr. Islam Dababseh in the Monthly Meeting of the American Society of Regenerative Medicine (ASRM)
